NCT07193199 - New Technique and Product for Chin Enhancement | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

May 24, 2026

Study Completion Date

June 24, 2026

Conditions

Aesthetic

Interventions

DEVICE

Revanesse Sculpt+

Revanesse Sculpt+ is approved and commercially available for use in Canada and is manufactured by Prollenium Technologies Inc. All study participants will receive Revanesse Sculpt+ for the treatment of mild to severe chin retrusion.

Trial Locations (1)

H3Z 1C3

Erevna Innovations Inc., Montreal